Martin Doorbar

Chief Development Officer; Non Clinical, Ellipses Pharma

Martin brings extensive experience of the full lifecycle of drug and medical device development covering pre-clinical stages through commercial approvals to global launches. In his career he has played a pivotal role in thirteen drug approvals and over forty IND / IMPD applications. Prior to joining Ellipses, Martin was Global Head of CMC and Manufacturing Operations with HUYA Bioscience International where he led the pharmaceutical development team. Martin began his career at Aventis and has held roles of increasing seniority with Juniper Pharmaceuticals, Mundipharma Research, Shire Pharmaceuticals, Innovata Biomed (now part of Vectura). Martin completed his BSc (Hons) in Applied & Analytical Chemistry at Staffordshire University.

Leonardo Royal Hotel London Tower Bridge

16 May 2023

The Mermaid, London

16 November 2023